Potential of PCSK9 as a New Target for the Management of LDL Cholesterol

Research Reports in Clinical Cardiology
doi 10.2147/rrcc.s52961
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Disadvantages of Current LDL-cholesterol Lowering and the Role of PCSK9 Inhibitors.

Cardiologia Croatica
Cardiovascular MedicineCardiology
2016English

Phenome-Wide Association Analysis of LDL-cholesterol Lowering Genetic Variants in PCSK9

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2019English

Cholesterol Metabolism: A Potential Therapeutic Target in Glioblastoma

Cancers
Cancer ResearchOncology
2019English

Protein Kinase D as a Potential New Target for Cancer Therapy

Biochimica et Biophysica Acta - Reviews on Cancer
Cancer ResearchOncologyGenetics
2010English

Effects of Currently Prescribed LDL-C-lowering Drugs on PCSK9 and Implications for the Next Generation of LDL-C-lowering Agents

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2011English

The Potential of Oxytocin as a Therapeutic Target for Psychiatric Disorders

Expert Opinion on Therapeutic Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2016English

Description of Discordance Between LDL Cholesterol, Non-HDL Cholesterol, and LDL Particle Number Among Patients of a Lipid Clinic

INNOVATIONS in pharmacy
2017English

Beyond Lowering LDL Cholesterol

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
2011English

Evaluation of Direct Assay Reagent for Determination of LDL-cholesterol.

Japanese journal of MHTS
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy